We recently presented to the Health Select Committee. Sincere thanks to the many brave patients and carers for their letters, which highlight the terrible inequity that exists for lung cancer in NZ. Click to view our submission – 2019 July – Lung Foundation NZ – Health Select Committee – Hearing for Lung Cancer Petition Petition […]
Today, five New Zealanders will die from lung cancer. A state that our cause is calling a national health emergency and requires urgent corrective action from the Government. This World Lung Cancer Day we urge the government to make funding standard of care treatments a national health priority. It is a national shame that New […]
This report provides a direct comparison of Non-Small Cell Lung Cancer Treatment Options: New Zealand and Australia versus European Society for Medical Oncology (ESMO) Guidelines. Sadly this report demonstrates how far behind Pharmac is with reimbursing standard of care treatments for NZ’s Biggest Cancer Killer and why lung cancer patients die prematurely in New Zealand. […]
“There are more than a hundred medicines on the PHARMAC waiting list. Some have been there five, ten or even fifteen years. I interviewed the Chief Executive of PHARMAC, Sarah Fitt, and asked her whether she was comfortable with that. Well, if there’s other medicines that have come along and replaced it. If there’s not […]
New Zealand is so far behind with access to standard of care treatments it is embarrassing. Lung cancer is the most targetable cancer. However, Pharmac policy is causing our most vulnerable to die prematurely.
WHEN: Tuesday 7 May 2019 10.45 am to 1.00 pm WHERE: Meet at the courtyard, outside Wellington Library, 65 Victoria Street. We will march to Pharmac at 40 Mercer Street, then along Willis Street and Lambton Quay, before arriving on the steps of Parliament. Click the link to view our poster – LFNZ Petition Submission […]
Dear Supporter Lung cancer kills more people in New Zealand every year, than breast cancer, prostate cancer and melanoma cancer combined, yet it is the least funded. Right now, we are witnessing unprecedented suffering and inequity in New Zealand, resulting in premature death for the majority of patients diagnosed with lung cancer. Sadly, almost 1900 […]
Despite lung cancer being NZ’s Biggest Cancer Killer, the top 3 lung cancer drugs funded by Pharmac (2017/18) equates to just 2.3% of the top 5 cancer drugs ($122 million).
Please stand with us by signing this petition. Together we can call on the Government to declare lung cancer a health priority and to approve additional budget for Pharmac to fund lung cancer medications, including Keytruda, Alectinib, Osimertinib and Crizotinib, for all Kiwis with advanced lung cancer, irrespective of socio-economic status. https://www.parliament.nz/en/pb/petitions/document/PET_86322/petition-of-philip-hope-for-lung-foundation-new-zealand?fbclid=IwAR0Er6gNod70xvpB1kq3bBVa0LExrfq8GSWo7Gv3KvV-Jr9vwb8mL-NsrDs
Lung Foundation NZ has filed a submission with Pharmac, urging them to do better for lung cancer – NZ’s Biggest Cancer Killer. A staggering imbalance exists, because of underfunding by Pharmac. For example; the top 3 lung cancer drugs reimbursed in NZ, represents less than 3% of the top 5 cancer drugs funded, despite lung […]